Moderna's Avian Flu Vaccine Contract Halted by Trump Administration in the U.S.
Moderna, the American pharmaceutical company, received a $590 million grant from the Biden administration in January to develop an avian flu vaccine for human use. However, tonight, Moderna announced that the development plan has been obstructed by the Trump administration, which has also revoked its procurement rights. This has raised concerns among experts about an increased risk of an avian flu pandemic.
